WGU D116 ADVANCED PHARMACOLOGY OA AND PRE
ASSESSMENT EXAM NEWEST 2025/2026
1. Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body and mechanisms of action
B) The study of drug absorption, distribution, metabolism, and excretion
(ADME)
C) The study of drug toxicity and adverse effects
D) The study of drug interactions with receptors
Answer: B
Rationale: Pharmacokinetics is defined as "what the body does to the
drug" and encompasses the four processes of Absorption, Distribution,
Metabolism, and Excretion (ADME). Pharmacodynamics, in contrast, is
"what the drug does to the body" – the study of drug effects and
mechanisms of action .
2. The "first-pass effect" refers to:
A) Rapid intravenous administration of a drug
B) Drug metabolism in the liver before reaching systemic circulation
C) Drug excretion by the kidneys after first administration
D) Drug binding to plasma proteins upon first exposure
Answer: B
Rationale: The first-pass effect occurs when a drug is metabolized in the
liver before reaching systemic circulation, reducing the bioavailability of
orally administered drugs. Drugs like nitroglycerin and morphine require
higher oral doses or alternative routes to bypass this effect. IV
administration bypasses first-pass metabolism entirely .
3. Bioavailability is defined as:
,A) The speed of drug absorption from the GI tract
B) The fraction of an administered dose that reaches systemic circulation
unchanged
C) The volume of distribution of the drug
D) The half-life of the drug
Answer: B
Rationale: Bioavailability measures how much of an administered dose
reaches the bloodstream unchanged. IV administration has 100%
bioavailability; oral bioavailability is reduced by first-pass metabolism
and absorption factors .
4. Which route of administration has the highest bioavailability and
fastest onset of action?
A) Oral
B) Subcutaneous
C) Intravenous (IV)
D) Intramuscular (IM)
Answer: C
Rationale: IV administration bypasses absorption barriers and first-pass
metabolism, delivering 100% of the dose to systemic circulation,
resulting in the highest bioavailability and fastest onset of action .
5. The volume of distribution (Vd) of a drug that is highly tissue-bound
will be:
A) Low
B) High
C) Zero
D) Negative
Answer: B
Rationale: High Vd indicates extensive tissue binding; low Vd indicates
primarily plasma binding. High Vd means most drug is in tissues, not
,plasma; this requires large loading doses to achieve therapeutic plasma
levels .
6. A drug with a high volume of distribution (e.g., digoxin) is
characterized by:
A) High plasma concentration
B) Low plasma concentration (distributes widely into tissues)
C) Rapid renal excretion
D) Minimal tissue binding
Answer: B
Rationale: High Vd means most drug is in tissues, not plasma; this
requires large loading doses to achieve therapeutic plasma levels.
Digoxin has a large Vd, making it widely distributed in tissues .
7. The half-life (t½) of a drug is:
A) The time required for 50% of the drug to be eliminated
B) The time required for the drug to reach peak concentration
C) The time required for the drug to be completely eliminated
D) The time required for the drug to reach steady state
Answer: A
Rationale: Half-life is the time required for the plasma concentration of a
drug to be reduced by 50%. It determines dosing interval; it takes
approximately 4-5 half-lives to reach steady state and to eliminate the
drug .
8. Steady state of a drug is typically reached after approximately:
A) One half-life
B) 2-3 half-lives
, C) 4-5 half-lives
D) 10 half-lives
Answer: C
Rationale: Steady state is reached when rate of drug administration
equals rate of elimination, usually after 4-5 half-lives. For an 8-hour half-
life drug: 4 × 8 = 32 hours to 5 × 8 = 40 hours to reach steady state .
9. The loading dose of a drug is intended to:
A) Maintain steady state
B) Achieve therapeutic levels rapidly
C) Decrease drug toxicity
D) Increase drug elimination
Answer: B
Rationale: A loading dose is administered to quickly achieve therapeutic
drug levels in the blood and tissues, bypassing the time needed to reach
steady state through maintenance dosing alone .
10. The therapeutic index (TI) of a drug is:
A) The ratio of the drug's effective dose to its toxic dose (TD50/ED50)
B) The ratio of the drug's toxic dose to its effective dose
C) The difference between the drug's effective dose and toxic dose
D) The sum of the drug's effective dose and toxic dose
Answer: A
Rationale: The therapeutic index is the ratio of the dose that produces
toxicity (TD50) to the dose that produces a therapeutic effect (ED50). A
narrow therapeutic index indicates that the drug has a small margin of
safety and requires careful monitoring. Examples include warfarin and
digoxin .
ASSESSMENT EXAM NEWEST 2025/2026
1. Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body and mechanisms of action
B) The study of drug absorption, distribution, metabolism, and excretion
(ADME)
C) The study of drug toxicity and adverse effects
D) The study of drug interactions with receptors
Answer: B
Rationale: Pharmacokinetics is defined as "what the body does to the
drug" and encompasses the four processes of Absorption, Distribution,
Metabolism, and Excretion (ADME). Pharmacodynamics, in contrast, is
"what the drug does to the body" – the study of drug effects and
mechanisms of action .
2. The "first-pass effect" refers to:
A) Rapid intravenous administration of a drug
B) Drug metabolism in the liver before reaching systemic circulation
C) Drug excretion by the kidneys after first administration
D) Drug binding to plasma proteins upon first exposure
Answer: B
Rationale: The first-pass effect occurs when a drug is metabolized in the
liver before reaching systemic circulation, reducing the bioavailability of
orally administered drugs. Drugs like nitroglycerin and morphine require
higher oral doses or alternative routes to bypass this effect. IV
administration bypasses first-pass metabolism entirely .
3. Bioavailability is defined as:
,A) The speed of drug absorption from the GI tract
B) The fraction of an administered dose that reaches systemic circulation
unchanged
C) The volume of distribution of the drug
D) The half-life of the drug
Answer: B
Rationale: Bioavailability measures how much of an administered dose
reaches the bloodstream unchanged. IV administration has 100%
bioavailability; oral bioavailability is reduced by first-pass metabolism
and absorption factors .
4. Which route of administration has the highest bioavailability and
fastest onset of action?
A) Oral
B) Subcutaneous
C) Intravenous (IV)
D) Intramuscular (IM)
Answer: C
Rationale: IV administration bypasses absorption barriers and first-pass
metabolism, delivering 100% of the dose to systemic circulation,
resulting in the highest bioavailability and fastest onset of action .
5. The volume of distribution (Vd) of a drug that is highly tissue-bound
will be:
A) Low
B) High
C) Zero
D) Negative
Answer: B
Rationale: High Vd indicates extensive tissue binding; low Vd indicates
primarily plasma binding. High Vd means most drug is in tissues, not
,plasma; this requires large loading doses to achieve therapeutic plasma
levels .
6. A drug with a high volume of distribution (e.g., digoxin) is
characterized by:
A) High plasma concentration
B) Low plasma concentration (distributes widely into tissues)
C) Rapid renal excretion
D) Minimal tissue binding
Answer: B
Rationale: High Vd means most drug is in tissues, not plasma; this
requires large loading doses to achieve therapeutic plasma levels.
Digoxin has a large Vd, making it widely distributed in tissues .
7. The half-life (t½) of a drug is:
A) The time required for 50% of the drug to be eliminated
B) The time required for the drug to reach peak concentration
C) The time required for the drug to be completely eliminated
D) The time required for the drug to reach steady state
Answer: A
Rationale: Half-life is the time required for the plasma concentration of a
drug to be reduced by 50%. It determines dosing interval; it takes
approximately 4-5 half-lives to reach steady state and to eliminate the
drug .
8. Steady state of a drug is typically reached after approximately:
A) One half-life
B) 2-3 half-lives
, C) 4-5 half-lives
D) 10 half-lives
Answer: C
Rationale: Steady state is reached when rate of drug administration
equals rate of elimination, usually after 4-5 half-lives. For an 8-hour half-
life drug: 4 × 8 = 32 hours to 5 × 8 = 40 hours to reach steady state .
9. The loading dose of a drug is intended to:
A) Maintain steady state
B) Achieve therapeutic levels rapidly
C) Decrease drug toxicity
D) Increase drug elimination
Answer: B
Rationale: A loading dose is administered to quickly achieve therapeutic
drug levels in the blood and tissues, bypassing the time needed to reach
steady state through maintenance dosing alone .
10. The therapeutic index (TI) of a drug is:
A) The ratio of the drug's effective dose to its toxic dose (TD50/ED50)
B) The ratio of the drug's toxic dose to its effective dose
C) The difference between the drug's effective dose and toxic dose
D) The sum of the drug's effective dose and toxic dose
Answer: A
Rationale: The therapeutic index is the ratio of the dose that produces
toxicity (TD50) to the dose that produces a therapeutic effect (ED50). A
narrow therapeutic index indicates that the drug has a small margin of
safety and requires careful monitoring. Examples include warfarin and
digoxin .
